Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

IQVIA to Participate in Baird 2019 Global Healthcare Conference on September 4, 2019


IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Baird 2019 Global Healthcare Conference in New York, NY on Wednesday, September 4, 2019 at 9:40 a.m. ET.

A live audio webcast of the presentation will be available on the IQVIA Investor Relations website, and a replay of the webcast also will be available beginning later that day. To access the webcast and recording, visit http://ir.iqvia.com.

About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science ?leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science ?to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA COREtm, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 61,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

IQVIAFIN

Click here to subscribe to Mobile Alerts for IQVIA.


These press releases may also interest you

at 16:20
Getaround Appoints New Independent Directors to Its Board
Getaround ("Getaround'' or "the Company"), the world's first connected carsharing marketplace, today announced three new additions to its Board of Directors. Nikul Patel, Neil Savage and Qais Sharif effective May 6, 2024. They will join existing...

at 16:15
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and six months ended March 31, 2024 and provided an...

at 16:13
FDA Roundup: May 10, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA provided information on how to safely charge hearing aids, glucose monitors, insulin pumps, and other medical...

at 16:10
JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider
JanOne Inc. announced today that it has executed a Definitive Agreement to acquire blockchain financial technology provider, ALT 5 Sigma Inc., a Delaware corporation, and each of its wholly-owned subsidiaries. The transaction is anticipated to close...

at 16:06
National Institute for Innovation and Technologytm Announces Groundbreaking Pre-Apprenticeship Program During Youth Apprenticeship Week
Amidst the excitement of Career and Technical Education (CTE) Signing Day, where students graduating from Capital Region BOCES CTE programs are matched with employers across the Capital Region, the National Institute for Innovation and Technologytm...

at 16:05
Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual Meeting
Scribe Therapeutics Inc. (Scribe), a genetic medicines company unlocking the potential of CRISPR to transform human health, presented data on its X-Editor (XE) and Epigenetic Long-Term X-Repressor (ELXR) technologies at the 27th American Society of...

More news about Science and technology...


News published on and distributed by: